Viewing nowRovitan Tablet 10 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

MFDS item code 201001008 · Approved 2010.01.28 · Insurance code 643902810
Improves dyslipidemia, slows the progression of atherosclerosis, and reduces cardiovascular disease risk
This medication is used as an adjunct when dietary changes and exercise alone are insufficient for patients with primary hypercholesterolemia and mixed dyslipidemia. It is also utilized as an adjunct in patients with homozygous familial hypercholesterolemia alongside dietary treatments or other lipid-lowering therapies. It helps to lower total cholesterol and LDL cholesterol in patients with hypercholesterolemia, thus delaying the progression of atherosclerosis. Specifically, it is used as an adjunct therapy for children and adolescents aged 10 to 17 years in high-risk groups to reduce cholesterol levels. It is also effective for patients with primary dysbetalipoproteinemia, helping to lower the risk of stroke, myocardial infarction, and revascularization procedures in elderly patients at high cardiovascular risk. Overall, this medication is used to improve blood lipid levels and reduce the risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication, and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted as a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased up to a maximum of 20 mg daily. 3. Older adults : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this medication at a dose of 20 mg to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 6. Race : Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (age 10 years to 17 years): The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on administering doses higher than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.
This medication should not be used in patients who are allergic to specific ingredients. Administration should be avoided in patients with liver issues or elevated liver enzyme levels. Patients with muscle diseases or concerns about muscle damage should not take this medication. Caution is required when taken with certain immunosuppressants due to potential risks. Patients with severe renal impairment or those who are pregnant or breastfeeding should not use this medication. High doses over 40 mg can increase the risk of muscle-related side effects, so careful attention is warranted. This medication contains lactose, so those with lactose intolerance should not take it. Patients who consume excessive alcohol or have a history of liver disease should have regular liver function tests. If symptoms of muscle pain or weakness arise, consult a doctor immediately and discontinue the medication if required. This medication can interact with other drugs, so inform your healthcare provider of any other medications being taken. Particularly when taken with fibrate-class drugs, the risk of muscle side effects increases, so caution is advised. Pregnant or breastfeeding women should avoid this medication as it may pose risks to the fetus or infant. In the case of overdose, there is no specific antidote, so immediate medical treatment is necessary, and liver and muscle status should be monitored. This medication may cause dizziness, so caution is needed when driving or operating machinery. If severe skin rashes or allergic reactions occur while taking this medication, discontinue use immediately and seek medical attention. For children and adolescents, it is recommended to regularly monitor growth and developmental status.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, dysesthesia, chest discomfort, anorexia, abdominal distension, syncope, myalgia, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it is best kept at room temperature between 1°C and 30°C. Avoid storing it in very hot or very cold places to maintain its effectiveness.
Pink round film-coated tablets
14 tablets/blister X 2
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.